Skip to main content
PRLD logo

PRLD · Prelude Therapeutics Inc

$4.06 -0.14 (-3.33%) At close · Jul 20
Market Cap
$323.36M
Shares
79.65M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
62/100
Short interest 3.5% of shares — P63 Days to cover 3.5 — P66 Price vs VWAP -9.7% — P30 Short-volume trend +9.5% — P81 Short interest change +57.4% — P89 Worst FTD 0.01% of shares — P39

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 2,822,240 1,792,865 +1,029,375 3.48
2026-06-15 1,792,865 1,693,810 +99,055 6.28
2026-05-29 1,693,810 1,851,622 -157,812 5.38
2026-05-15 1,851,622 1,554,997 +296,625 3.54
2026-04-30 1,554,997 1,807,780 -252,783 2.68
2026-04-15 1,807,780 2,319,677 -511,897 5.19
2026-03-31 2,319,677 2,275,949 +43,728 13.77
2026-03-13 2,275,949 2,272,634 +3,315 8.10
2026-02-27 2,272,634 2,378,569 -105,935 6.23
2026-02-13 2,378,569 2,074,354 +304,215 8.92
2026-01-30 2,074,354 1,677,134 +397,220 4.78
2026-01-15 1,677,134 1,472,870 +204,264 3.11
2025-12-31 1,472,870 1,279,653 +193,217 2.62
2025-12-15 1,279,653 995,838 +283,815 3.32
2025-11-28 995,838 1,277,843 -282,005 2.05
2025-11-14 1,277,843 567,052 +710,791 1.00
2025-10-31 567,052 515,090 +51,962 2.11
2025-10-15 515,090 601,130 -86,040 2.38
2025-09-30 601,130 538,367 +62,763 1.62
2025-09-15 538,367 531,205 +7,162 4.06
2025-08-29 531,205 510,202 +21,003 1.75
2025-08-15 510,202 594,635 -84,433 4.53
2025-07-31 594,635 520,771 +73,864 4.34
Showing 1–23 of 23 settlements
Key facts CIK 1678660 CUSIP 74065P101 13F (30d) 2 filings 2 filers Visit website Investor relations